Eli Lilly and Company (LLY) News Today $854.40 +8.68 (+1.03%) Closing price 10/9/2025 03:59 PM EasternExtended Trading$851.48 -2.92 (-0.34%) As of 04:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Eli Lilly and Company Up Today?Toggle Visibility of Why Is Eli Lilly and Company Up Today?Eli Lilly and Company (NYSE: LLY) shares are trading higher today, buoyed by a string of positive clinical updates, strategic partnerships, and strong sector momentum. Recent news items impacting LLY include: Positive Sentiment: Eli Lilly initiated a Phase 3 trial of orforglipron for stress urinary incontinence, potentially addressing a large, unmet market. Orforglipron study Positive Sentiment: A new Eli Lilly-led clinical study for a liver disease therapy was announced, promising to expand the company’s pipeline into hepatology. Liver disease study Positive Sentiment: Eli Lilly completed a Phase 1 trial combining bimagrumab and tirzepatide, with early data suggesting synergistic metabolic benefits. Bimagrumab/tirzepatide study Positive Sentiment: A two-part Phase 3 trial of a novel ovarian cancer treatment showed promising early enrollment and biomarker results. Ovarian cancer study Positive Sentiment: The LY4337713 cancer candidate entered a new clinical study, underscoring Lilly’s oncology expansion. LY4337713 study Positive Sentiment: Richmond United will vacate its soccer complex to make way for a new $5 billion Eli Lilly pharmaceutical manufacturing facility, boosting production capacity. Richmond facility Positive Sentiment: HealthTap joined Lilly’s digital health platform LillyDirect to expand virtual diabetes management services. HealthTap partnership Positive Sentiment: Eli Lilly hired a former FDA vaccine regulator to bolster its biologics oversight, strengthening its regulatory expertise. FDA regulator hire Positive Sentiment: Peter Marks, ex-US FDA official, was tapped to lead Lilly’s infectious disease unit, underscoring focus on anti-infectives. Peter Marks hire Positive Sentiment: A Zacks analysis highlighted Lilly’s explosive GLP-1 franchise growth as a competitive edge against AbbVie in 2025. AbbVie vs. Eli Lilly Positive Sentiment: MarketBeat’s sector roundup named Eli Lilly among the top five healthcare plays powering a comeback, citing its leadership in diabetes and obesity treatments. 5 Healthcare Plays Positive Sentiment: A MarketBeat screener featured LLY in its “Best Pharmaceutical Stocks To Add to Your Watchlist” list for October 9th. Best Pharmaceutical Stocks To Add Neutral Sentiment: MarketBeat maintained LLY in its “Best Pharmaceutical Stocks To Watch Now” list for October 8th. Best Pharmaceutical Stocks To Watch Now Neutral Sentiment: Weiss Ratings reaffirmed a Hold (C+) rating on LLY shares. Weiss Ratings Neutral Sentiment: MarketBeat also reported Weiss Ratings’ Hold (C+) rating reaffirmation on October 8th. Hold Rating Reaffirmed Neutral Sentiment: MMM-Online’s “The Escalator” named Eli Lilly among several biotech companies in its daily industry update. The Escalator Negative Sentiment: Lilly Endowment Inc., a major shareholder, sold LLY stock, indicating insider profit-taking. Insider Trading Negative Sentiment: Roche’s GLP-1 candidate entered Phase 3, marking intensifying competition in Lilly’s key obesity market. Roche competitor Posted 8h agoAI Generated. May Contain Errors. LLY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Eli Lilly and Company (NYSE:LLY) Shares Up 1% - Should You Buy?5 hours ago | marketbeat.comMajor Shareholder Cashes Out Millions in Eli Lilly Stock!October 9 at 10:10 PM | tipranks.comBest Pharmaceutical Stocks To Add to Your Watchlist - October 9thOctober 9 at 3:14 PM | marketbeat.comEli Lilly’s New Study on Orforglipron: A Potential Game-Changer for Stress Urinary IncontinenceOctober 9 at 12:51 PM | tipranks.comEli Lilly’s New Study on Liver Disease: A Potential Game-Changer for InvestorsOctober 9 at 12:51 PM | tipranks.comEli Lilly Completes Phase 1 Study on Bimagrumab and Tirzepatide: Market ImplicationsOctober 9 at 12:31 PM | tipranks.comEli Lilly’s Promising Phase 3 Study on Ovarian Cancer Treatment: A Potential Game-ChangerOctober 9 at 12:31 PM | tipranks.comEli Lilly’s New Study on LY4337713: A Potential Game-Changer for Cancer TreatmentOctober 9 at 12:31 PM | tipranks.comWatch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity MarketOctober 9 at 8:10 AM | fool.com5 Healthcare Plays Powering the Sector’s Big Comeback (LLY)After years of lagging, the healthcare sector is showing signs of a turnaround driven by lower rates, policy clarity, and renewed investor interest.October 9 at 8:03 AM | marketbeat.comArmstrong Fleming & Moore Inc Purchases 501 Shares of Eli Lilly and Company $LLYOctober 9 at 6:01 AM | marketbeat.comNotis McConarty Edward Acquires 1,424 Shares of Eli Lilly and Company $LLYOctober 9 at 5:33 AM | marketbeat.comEli Lilly and Company $LLY is Trifecta Capital Advisors LLC's 7th Largest PositionOctober 9 at 5:25 AM | marketbeat.comMaryland State Retirement & Pension System Buys 1,299 Shares of Eli Lilly and Company $LLYOctober 9 at 5:16 AM | marketbeat.comCapital Management Associates Inc Cuts Stock Position in Eli Lilly and Company $LLYOctober 9 at 5:07 AM | marketbeat.comSitrin Capital Management LLC Sells 566 Shares of Eli Lilly and Company $LLYOctober 9 at 5:07 AM | marketbeat.comDempze Nancy E Increases Stock Holdings in Eli Lilly and Company $LLYOctober 9 at 5:07 AM | marketbeat.comFirst Merchants Corp Has $39.09 Million Stock Position in Eli Lilly and Company $LLYOctober 9 at 5:06 AM | marketbeat.comEli Lilly and Company $LLY Shares Sold by Bar Harbor Wealth ManagementOctober 9 at 4:46 AM | marketbeat.comNarwhal Capital Management Acquires 3,845 Shares of Eli Lilly and Company $LLYOctober 9 at 4:46 AM | marketbeat.comEli Lilly and Company $LLY Shares Bought by Dohj LLCOctober 9 at 4:46 AM | marketbeat.comCastle Rock Wealth Management LLC Sells 1,218 Shares of Eli Lilly and Company $LLYOctober 9 at 4:37 AM | marketbeat.comValmark Advisers Inc. Has $4.23 Million Stock Holdings in Eli Lilly and Company $LLYOctober 9 at 4:37 AM | marketbeat.comEli Lilly and Company's (LLY) Hold (C+) Rating Reaffirmed at Weiss RatingsOctober 8 at 12:52 AM | marketbeat.comMajor Shareholder Cashes In on Eli Lilly & Co Stock!October 8 at 10:11 PM | tipranks.comBest Pharmaceutical Stocks To Watch Now - October 8thOctober 8 at 3:08 PM | marketbeat.comEli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For WednesdayOctober 8 at 10:31 AM | benzinga.comHealthTap joins Lilly's online platform to offer diabetes management servicesOctober 8 at 8:18 AM | reuters.comEli Lilly and Company $LLY Shares Bought by Lansing Street AdvisorsOctober 8 at 6:34 AM | marketbeat.comPuzo Michael J Has $3.57 Million Holdings in Eli Lilly and Company $LLYOctober 8 at 6:17 AM | marketbeat.comEli Lilly and Company $LLY Shares Sold by Raub Brock Capital Management LPOctober 8 at 6:17 AM | marketbeat.comEli Lilly and Company $LLY Shares Acquired by Citizens National Bank Trust DepartmentOctober 8 at 6:17 AM | marketbeat.comEli Lilly and Company $LLY Shares Purchased by Broderick Brian COctober 8 at 6:16 AM | marketbeat.comKidder Stephen W Grows Stock Holdings in Eli Lilly and Company $LLYOctober 8 at 6:06 AM | marketbeat.com1,415 Shares in Eli Lilly and Company $LLY Purchased by Secured Retirement Advisors LLCOctober 8 at 6:05 AM | marketbeat.comSomerville Kurt F Has $5.65 Million Stock Position in Eli Lilly and Company $LLYOctober 8 at 5:49 AM | marketbeat.comMirova US LLC Trims Stake in Eli Lilly and Company $LLYOctober 8 at 5:48 AM | marketbeat.comProffitt & Goodson Inc. Grows Stock Holdings in Eli Lilly and Company $LLYOctober 8 at 5:47 AM | marketbeat.comFormer FDA vaccine regulator takes job at Eli LillyOctober 8 at 5:41 AM | msn.comEli Lilly taps former US FDA official Peter Marks to head infectious diseaseOctober 8 at 5:41 AM | msn.comLouisiana State Employees Retirement System Sells 900 Shares of Eli Lilly and Company $LLYOctober 8 at 5:39 AM | marketbeat.comVenturi Wealth Management LLC Buys 1,288 Shares of Eli Lilly and Company $LLYOctober 8 at 5:31 AM | marketbeat.comCanopy Partners LLC Buys 428 Shares of Eli Lilly and Company $LLYOctober 8 at 5:02 AM | marketbeat.comShell Asset Management Co. Increases Position in Eli Lilly and Company $LLYOctober 8 at 5:01 AM | marketbeat.comFormer FDA vaccine chief Peter Marks joins Eli LillyOctober 7 at 12:41 AM | msn.comEli Lilly’s $1 billion India investment to boost local CMOs and suppliersOctober 7 at 12:41 AM | msn.comFormer Top FDA Official, Forced Out by Kennedy, Lands at Eli LillyOctober 7 at 7:40 PM | msn.comEli Lilly: Beyond Weight LossOctober 7 at 6:11 PM | finance.yahoo.comFormer FDA vaccine chief Peter Marks joins Eli Lilly, STAT reportsOctober 7 at 3:16 PM | reuters.comBest Pharmaceutical Stocks To Watch Today - October 7thOctober 7 at 3:12 PM | marketbeat.com Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos LLY Media Mentions By Week LLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼1.230.77▲Average Medical News Sentiment LLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼15558▲LLY Articles Average Week Get the Latest News and Ratings for LLY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Eli Lilly and Company and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amgen News Today Biogen News Today Incyte News Today Moderna News Today Viking Therapeutics News Today Vertex Pharmaceuticals News Today AbbVie News Today Johnson & Johnson News Today Merck & Co., Inc. News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
